Evidence map›Paper›PMID 24586659›Full record

ArticlePloS one2014

Positive regulation of TRAF6-dependent innate immune responses by protein phosphatase PP1-γ.

Amanda M Opaluch, Monika Schneider, Chih-yuan Chiang, Quy T Nguyen, Ana M Maestre, Lubbertus C F Mulder, Ismael Secundino, Paul D De Jesus, Renate König, Viviana Simon and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Protein phosphatases in TLR signaling.Cell communication and signaling : CCS · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Amanda M OpaluchInfectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, California, United States of America.
Monika SchneiderInfectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, California, United States of America.
Chih-yuan ChiangInfectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, California, United States of America.
Quy T NguyenInfectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, California, United States of America.
Ana M MaestreDepartment of Microbiology and The Global Health and Emerging Pathogens Institute, Mount Sinai School of Medicine, New York, New York, United States of America.
Lubbertus C F MulderDepartment of Microbiology and The Global Health and Emerging Pathogens Institute, Mount Sinai School of Medicine, New York, New York, United States of America.
Ismael SecundinoDepartment of Pediatrics, University of California San Diego, La Jolla, California, United States of America.
Paul D De JesusInfectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, California, United States of America.
Renate KönigInfectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, California, United States of America ; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Research Group "Host-Pathogen Interactions", Langen, Germany.
Viviana SimonDepartment of Microbiology and The Global Health and Emerging Pathogens Institute, Mount Sinai School of Medicine, New York, New York, United States of America.
Victor NizetDepartment of Pediatrics, University of California San Diego, La Jolla, California, United States of America ; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, United States of America.
Graham MacLeodDepartment of Cell and Systems Biology, University of Toronto, Toronto, Ontario, Canada.
Susannah VarmuzaDepartment of Cell and Systems Biology, University of Toronto, Toronto, Ontario, Canada.
Ana Fernandez-SesmaDepartment of Microbiology and The Global Health and Emerging Pathogens Institute, Mount Sinai School of Medicine, New York, New York, United States of America.
Sumit K ChandaInfectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, California, United States of America.
Sanford Burnham Prebys Medical Discovery Institute · USIcahn School of Medicine at Mount Sinai · USUniversity of Toronto · CAPaul Ehrlich Institut · DEUniversity of California, San Diego · USUniversity of Montana · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Michael Jackson · 1985 to 2026
$107.2M
SYNTHETIC SYSTEMSP50GM085764 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HASTY, JEFF M, IDEKER, TREY · 2010 to 2018
$23.3M
Molecular Virology and Systems Biology Screening CoreP01AI090935 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI CHANDA, SUMIT K · 2010 to 2014
$20.4M
GAS Switch from Colonizing Bacterium to Invasive PathogenR01AI077780 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIZET, VICTOR · 2008 to 2019
$3.8M
HIV Evolution Driven by Intracellular DefensesR01AI064001 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SIMON, VIVIANA A · 2005 to 2015
$3.8M
MODULATION OF INNATE AND ADAPTIVE IMMUNITY BY DENGUE VIRUSR01AI073450 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FERNANDEZ-SESMA, ANA · 2008 to 2017
$3.3M
Genomic Determinants of Intrinsic Antiviral Host DefensesR01AI089246 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SIMON, VIVIANA A · 2010 to 2014
$2.1M
Genome stability function of APOBEC3 retroviral restriction factorsR21AI096943 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MULDER, LUBBERTUS C · 2011 to 2012
$466k
Identification of age-related mediators of pro-inflammatory signalingF31AG032171 · NIA · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI OPALUCH, AMANDA · 2008 to 2010
$91k
NCI NIH HHS P30 CA030199NIAID NIH HHS 1P01AI90935-01NIAID NIH HHS 1R011AI073450-01A2NIAID NIH HHS AI096943NIAID NIH HHS AI77780NIAID NIH HHS P01 AI090935NIAID NIH HHS R01 AI064001NIAID NIH HHS R01 AI073450NIAID NIH HHS R01 AI077780NIAID NIH HHS R01 AI089246NIAID NIH HHS R21 AI096943NIA NIH HHS F31 AG032171NIGMS NIH HHS P50 GM085764PHS HHS 1 P50 NIGMS085764-01A2
6 · The paper itself

Abstract

Innate immune sensors such as Toll-like receptors (TLRs) differentially utilize adaptor proteins and additional molecular mediators to ensure robust and precise immune responses to pathogen challenge. Through a gain-of-function genetic screen, we identified the gamma catalytic subunit of protein phosphatase 1 (PP1-γ) as a positive regulator of MyD88-dependent proinflammatory innate immune activation. PP1-γ physically interacts with the E3 ubiquitin ligase TRAF6, and enhances the activity of TRAF6 towards itself and substrates such as IKKγ, whereas enzymatically inactive PP1-γ represses these events. Importantly, these activities were found to be critical for cellular innate responses to pathogen challenge and microbial clearance in both mouse macrophages and human monocyte lines. These data indicate that PP1-γ phosphatase activity regulates overall TRAF6 E3 ubiquitin ligase function and promotes NF-κB-mediated innate signaling responses.

Indexed as

Gene Expression RegulationImmunity, InnateAnimalsBlotting, WesternCells, CulturedDendritic CellsEnzyme-Linked Immunosorbent AssayHigh-Throughput Nucleotide SequencingHumansImmunoprecipitationMacrophagesMiceMutationMyeloid Differentiation Factor 88NF-kappa BProtein Phosphatase 1MYD88 protein, humanMyeloid Differentiation Factor 88NF-kappa BPpp1cc protein, mouseProtein Phosphatase 1RNA, MessengerRNA, Small InterferingTNF Receptor-Associated Factor 6Toll-Like Receptors

Identifiers

PMID24586659
PMCPMC3930702
OpenAlexW1997617537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.